Management of dermatological adverse reactions in patients undergoing antineoplastic chemotherapy

Authors

  • JANE BEATRIZ LIMBERGER UNIVERSIDADE FRANCISCANA - UFN
  • CAROLINA DIAS SCHAFER Universidade Franciscana - UFN

DOI:

https://doi.org/10.9771/cmbio.v22i1.37960

Keywords:

antineoplastics; skin and subcutaneous tissue; hypersensitivity to drugs; exanthema; quality of life.

Abstract

Objective: the present study aims to gather care recommendations considering the prevention and treatment of skin lesions induced by treatment with antineoplastic chemotherapy, according to current studies and consensus. Methodology: a bibliographical study was carried out to survey the relationships between the main antineoplastic drugs and their dermatological intercurrences, as well as their respective management, to subsidize the guidance and counselling of health professionals who treat cancer patients. Result: the main dermatological problems arising from the use of antineoplastic agents correspond to skin lesions, such as discoloration, hyperpigmentation, photosensitivity, erythema, scaling and pruritus. Adverse effects that affect hair and body hair are also recurrent, resulting in alopecia, and the modification of growth and lesions on the nails. Specific treatments for each case can alleviate or reverse the problems. Conclusion: adverse drug reactions involving chemotherapy are frequent in oncology practice, and vary in terms of frequency and severity, affecting various skin appendages. Proper management of these effects improves the integrity of the skin and other structures, providing these patients with improved self-esteem and quality of life.

 

Downloads

Download data is not yet available.

Author Biographies

JANE BEATRIZ LIMBERGER, UNIVERSIDADE FRANCISCANA - UFN

Docente do curso de Farmácia - Universidade Franciscana

CAROLINA DIAS SCHAFER, Universidade Franciscana - UFN

Acadêmica do curso de Farmácia - UFN

Published

2023-06-22

How to Cite

LIMBERGER, J. B., & SCHAFER, C. D. (2023). Management of dermatological adverse reactions in patients undergoing antineoplastic chemotherapy. Journal of Medical and Biological Sciences, 22(1), 153–161. https://doi.org/10.9771/cmbio.v22i1.37960